Heteroresistance to rifampicin & isoniazid in clinical samples of patients with presumptive drug-resistant tuberculosis in Central India
Open Access
- 3 May 2023
- journal article
- research article
- Published by Scientific Scholar in Indian Journal of Medical Research
- Vol. 157 (2&3) , 174-182
Abstract
Background & objectives: A combination of resistant and susceptible Mycobacterium tuberculosis (MTB) isolated from clinical specimens is referred to as heteroresistance. Heteroresistance leads to difficulties in drug resistance testing and may adversely affect treatment outcomes. The present study estimated the proportion of heteroresistance among MTB in clinical samples of presumptive drug-resistant tuberculosis (TB) patients in Central India. Methods: A retrospective analysis of data generated from line probe assay (LPA) at a tertiary care hospital in Central India between January 2013 and December 2018 was carried out. A heteroresistant MTB in a sample was indicated by the presence of both wild-type and mutant-type patterns on an LPA strip. Results: Data analysis was carried out on interpretable 11,788 LPA results. Heteroresistance in MTB was detected in 637 (5.4%) samples. Of these, heteroresistance in MTB was detected in 413 (64.8%), 163 (25.5%) and 61 (9.5%) samples with respect to rpoB, katG and inhA genes, respectively. Interpretation & conclusions: Heteroresistance is considered a preliminary step in the development of drug resistance. Delayed or suboptimal anti-tubercular therapy in patients with heteroresistance of MTB may elicit full clinical resistance and negatively impact the National TB Elimination Programme. Further studies are, however, needed to determine the impact of heteroresistance on treatment outcomes in individual patients.Keywords
This publication has 35 references indexed in Scilit:
- Multidrug-resistant and heteroresistant Mycobacterium tuberculosis and associated gene mutations in EthiopiaInternational Journal of Infectious Diseases, 2015
- Molecular profiling of drug resistant isolates of Mycobacterium tuberculosis in the state of Santa Catarina, southern BrazilMemórias do Instituto Oswaldo Cruz, 2015
- Mixed Infections and Rifampin Heteroresistance among Mycobacterium tuberculosis Clinical IsolatesJournal of Clinical Microbiology, 2015
- Utility of line probe assay for the early detection of multidrug-resistant pulmonary tuberculosisJournal of Global Infectious Diseases, 2015
- High degree of multi-drug resistance and hetero-resistance in pulmonary TB patients from Punjab state of IndiaTuberculosis, 2014
- Detection of Heteroresistant Mycobacterium tuberculosis by PyrosequencingJournal of Clinical Microbiology, 2013
- Rifampin Heteroresistance in Mycobacterium tuberculosis Cultures as Detected by Phenotypic and Genotypic Drug Susceptibility Test MethodsJournal of Clinical Microbiology, 2013
- Subpopulation Analysis of Heteroresistance to Fluoroquinolone in Mycobacterium tuberculosis Isolates from Beijing, ChinaJournal of Clinical Microbiology, 2012
- Mechanisms of heteroresistance to isoniazid and rifampin ofMycobacterium tuberculosisin Tashkent, UzbekistanEuropean Respiratory Journal, 2008
- Use of Genotype MTBDR Assay for Molecular Detection of Rifampin and Isoniazid Resistance in Mycobacterium tuberculosis Clinical Strains Isolated in ItalyJournal of Clinical Microbiology, 2006